FDA seeks comments on combined-function molecular Dx proposal

04/11/2013 | GenomeWeb Daily News (free registration)

The FDA has released draft guidance on how it intends to regulate molecular diagnostic systems with combined functions. The agency is seeking comments on the guidance, which covers issues such as submission data, device labeling and promotion, and modifications of software and hardware.

View Full Article in:

GenomeWeb Daily News (free registration)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Manager, Business Conduct
Gilead
Foster City, CA
Product Patent Attorney
Gilead
Foster City, CA
Employment Counsel
Gilead
Foster City, CA
Junior to Mid-Level FDA Associate
Morgan Lewis
Washington, DC
Global Counsel - Advertising and Promotions
Mylan Inc.
Washington, DC